GlassScriptPhysician profile
Grace Elizabeth Brown
NPI 1164656054
$8,062.90
in general payments reported to CMS, 2019-2025
41 companies · $2,031 in 2025
The $2,031 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $746 · 2021: $742 · 2022: $732 · 2023: $1,517 · 2024: $1,510 · 2025: $2,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,951 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,950.50 |
| Education | $107.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,084.37 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $1,009.21 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Sun Pharmaceutical Industries INC. | $693.09 | 2019-2025 | Winlevi, Absorica Ld, Ilumya |
| Arcutis Biotherapeutics, INC. | $594.78 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $433.04 | 2019-2025 | Dupixent, Libtayo |
| Mayne Pharma Commercial LLC | $342.92 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $321.12 | 2019-2025 | Cabtreo, Jublia, Siliq |
| Lilly USA, LLC | $311.94 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $299.27 | 2020-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $277.52 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $275.64 | 2019-2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $272.20 | 2019-2025 | |
| Pfizer INC. | $250.02 | 2019-2025 | |
| Incyte Corporation | $244.28 | 2023-2025 | Opzelura |
| Ucb, INC. | $203.56 | 2019-2024 | Bimzelx |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.